PMC3934680_01
Chest contrast-enhanced CT showed mediastinal tumor with lymph node enlargement surrounding the trachea.
cro-0007-0065-g01.jpg
PMC3934680_01_cro-0007-0065-g01.jpg
F1
Chest computed tomography (CT) revealed an abnormal mass in the anterior and middle mediastinum (fig. 1). 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) showed positive uptake in the mediastinal mass and right supraclavicular lymph node (fig. 2).
FDG-PET before treatment revealed increased uptake in the mediastinal lesion and right supraclavicular lymph node.
cro-0007-0065-g02.jpg
PMC3934680_01_cro-0007-0065-g02.jpg
F2
Chest computed tomography (CT) revealed an abnormal mass in the anterior and middle mediastinum (fig. 1). 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) showed positive uptake in the mediastinal mass and right supraclavicular lymph node (fig. 2).
Chest contrast-enhanced CT showed a reduced mediastinal mass after 4 cycles of chemotherapy and concurrent thoracic radiotherapy.
cro-0007-0065-g03.jpg
PMC3934680_01_cro-0007-0065-g03.jpg
F3
Partial response was achieved when 4 cycles of chemotherapy had been completed (fig. 3).